{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:44:13Z","timestamp":1794347053451,"version":"4.9.0"},"publisher-location":"Chichester, UK","reference-count":38,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005494.pub2","type":"reference-entry","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T10:37:15Z","timestamp":1183459035000},"source":"Crossref","is-referenced-by-count":14,"title":["Sildenafil for pulmonary hypertension in neonates"],"prefix":"10.1002","author":[{"given":"Prakeshkumar S","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,7,18]]},"reference":[{"key":"10.1002\/14651858.CD005494.pub2-BIB1|cit1","first-page":"2119","article-title":"Outcome at 18 months of age after sildenafil therapy for refractory neonatal hypoxemia","volume":"57","author":"Baquero","year":"2005","journal-title":"E-PAS"},{"key":"10.1002\/14651858.CD005494.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.2005-0523","article-title":"Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study","volume":"117","author":"Baquero","year":"2006","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD005494.pub2-BIB3|cit3","series-title":"E-PAS2006:59:3724.3","article-title":"Oral sildenafil treatment as an alternative to inhaled NO therapy for persistent pulmonary hypertension of the newborn","author":"Herrea"},{"key":"10.1002\/14651858.CD005494.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.200605-694OC","article-title":"Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children","volume":"174","author":"Namachivayam","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD005494.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1136\/heart.84.2.e4","article-title":"Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension","volume":"84","author":"Abrams","year":"2000","journal-title":"Heart"},{"key":"10.1002\/14651858.CD005494.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00008480-200206000-00002","article-title":"Recent advances in pulmonary vascular disease","volume":"14","author":"Adatia","year":"2002","journal-title":"Current Opinion in Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD005494.pub2-BIB7|cit7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000509","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants","author":"Barrington","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005494.pub2-BIB8|cit8","first-page":"523","article-title":"Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase","volume":"42","author":"Behn","year":"2001","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD005494.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/eye.2000.205","article-title":"Sildenafil (Viagra) a cause of proliferative diabetic retinopathy?","volume":"14","author":"Burton","year":"2000","journal-title":"Eye"},{"key":"10.1002\/14651858.CD005494.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/adc.88.9.827","article-title":"Sildenafil as a treatment for pulmonary hypertension","volume":"88","author":"Carroll","year":"2003","journal-title":"Archives of Disease of Childhood"},{"key":"10.1002\/14651858.CD005494.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1203\/00006450-199812000-00002","article-title":"Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension","volume":"44","author":"Dukarm","year":"1998","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD005494.pub2-BIB12|cit12","doi-asserted-by":"crossref","unstructured":"Erickson S Reyes J Bohn D Adatia I Sildenafil (Viagra) in childhood and neonatal pulmonary hypertension Journal of the American College of Cardiology (suppl) 2002 402A","DOI":"10.1016\/S0735-1097(02)81805-8"},{"issue":"2","key":"10.1002\/14651858.CD005494.pub2-BIB13|cit13","article-title":"Nitric oxide for respiratory failure in infants born at or near term","author":"Finer","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005494.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0095-5108(18)30899-6","article-title":"Neonatal pulmonary hypertension: pathophysiology, classification, and etiology","volume":"11","author":"Gersony","year":"1984","journal-title":"Clinics in Perinatology"},{"key":"10.1002\/14651858.CD005494.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1542\/peds.98.4.706","article-title":"Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn","volume":"98","author":"Goldman","year":"1996","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD005494.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005494.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00003246-200105000-00024","article-title":"Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension","volume":"29","author":"Ichinose","year":"2001","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD005494.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.fjc.0000155386.49103.ce","article-title":"Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension","volume":"45","author":"Ikeda","year":"2005","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD005494.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00431-005-1724-x","article-title":"Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil","volume":"164","author":"Juliana","year":"2005","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD005494.pub2-BIB20|cit20","article-title":"Sildenafil for pulmonary hypertension","author":"Kanthapillai","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005494.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/sper.2000.20085","article-title":"Inhaled nitric oxide: current and future uses in neonates","volume":"24","author":"Kinsella","year":"2000","journal-title":"Seminars in Perinatology"},{"key":"10.1002\/14651858.CD005494.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bmj.325.7357.181","article-title":"Indian doctor in protest after using Viagra to save \"blue babies\"","volume":"325","author":"Kumar","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005494.pub2-BIB23|cit23","first-page":"894","article-title":"Viagra neonatal experimentation - the Pandora's box!","volume":"39","author":"Lewin","year":"2002","journal-title":"Indian Pediatrics"},{"key":"10.1002\/14651858.CD005494.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bjo.2003.021956","article-title":"Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension","volume":"88","author":"Marsh","year":"2004","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD005494.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/bmj.325.7373.1174\/a","article-title":"Sildenafil for \"blue babies\". Such unlicensed drug use might be justified as last resort","volume":"325","author":"Oliver","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005494.pub2-BIB26|cit26","first-page":"1174","article-title":"Sildenafil for \"blue babies\". Ethics, conscience, and science have to be balanced against limited resources","volume":"325","author":"Patole","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005494.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/bjo.2004.054023","article-title":"No evidence for severe retinopathy of prematurity following sildenafil","volume":"89","author":"Pierce","year":"2005","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD005494.pub2-BIB28|cit28","first-page":"L536","article-title":"Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors","volume":"266","author":"Rabe","year":"1994","journal-title":"American Journal of Physiology"},{"key":"10.1002\/14651858.CD005494.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group","volume":"336","author":"Roberts","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005494.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension","volume":"43","author":"Sastry","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD005494.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1515\/JPM.2004.030","article-title":"Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn","volume":"32","author":"Shah","year":"2004","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD005494.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/ajrccm.165.8.2107097","article-title":"Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension","volume":"165","author":"Shekerdemian","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD005494.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1203\/01.PDR.0000112033.81970.C2","article-title":"Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome","volume":"55","author":"Shekerdemian","year":"2004","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD005494.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4314\/eamj.v83i6.9442","article-title":"Sildenafil in management of persistent pulmonary hypertension of the newborn: report of two cases","volume":"83","author":"Simiyu","year":"2006","journal-title":"East African Medical Journal"},{"key":"10.1002\/14651858.CD005494.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(02)08632-4","article-title":"Cost of inhaled nitric oxide therapy in neonates","volume":"359","author":"Subhedar","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005494.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ppul.10389","article-title":"Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review","volume":"36","author":"Travadi","year":"2003","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD005494.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD005494.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1542\/peds.100.5.e7","article-title":"Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn","volume":"100","author":"Wessel","year":"1997","journal-title":"Pediatrics"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005494.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T16:59:04Z","timestamp":1683910744000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005494.pub2"}},"subtitle":[],"editor":[{"given":"Prakeshkumar S","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,7,18]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005494.pub2","relation":{},"subject":[],"published":{"date-parts":[[2007,7,18]]}}}